1. Home
  2. SKY vs LEGN Comparison

SKY vs LEGN Comparison

Compare SKY & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Skyline Champion Corporation

SKY

Skyline Champion Corporation

N/A

Current Price

$91.83

Market Cap

4.3B

ML Signal

N/A

Logo Legend Biotech Corporation

LEGN

Legend Biotech Corporation

N/A

Current Price

$23.37

Market Cap

4.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SKY
LEGN
Founded
2010
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3B
4.2B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
SKY
LEGN
Price
$91.83
$23.37
Analyst Decision
Buy
Buy
Analyst Count
7
13
Target Price
★ $101.83
$45.62
AVG Volume (30 Days)
680.3K
★ 2.0M
Earning Date
11-03-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 7.02
N/A
EPS
★ 1.86
N/A
Revenue
★ $2,663,639,000.00
N/A
Revenue This Year
$4.80
$39.73
Revenue Next Year
$7.49
$23.42
P/E Ratio
$51.70
★ N/A
Revenue Growth
★ 7.26
N/A
52 Week Low
$63.87
$16.24
52 Week High
$99.17
$37.50

Technical Indicators

Market Signals
Indicator
SKY
LEGN
Relative Strength Index (RSI) 61.88 67.14
Support Level $89.31 $22.40
Resistance Level $97.54 $23.65
Average True Range (ATR) 3.44 1.19
MACD 1.89 0.33
Stochastic Oscillator 76.29 89.43

Price Performance

Historical Comparison
SKY
LEGN

About SKY Skyline Champion Corporation

Champion Homes Inc is a factory-built housing company in North America. The company is well positioned with an portfolio of manufactured and modular homes, ADUs, park-models and modular buildings for the single-family, multi-family, and other hospitality sectors. In addition to its core home building business, the company provides construction services to install and set-up factory-built homes, operates a factory-direct retail business across the United States, and operates Star Fleet Trucking, providing transportation services to the manufactured housing and other industries from several locations across the US. The Company has two reportable segment U.S. Factory-built Housing and Canadian Factory-built Housing. The majority of the revenue is generated from U.S. Factory-built Housing.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: